Results 91 to 100 of about 19,293 (297)
Background Peritoneal metastasis (PM) is a late-stage manifestation of intra-abdominal malignancies. The current standard of care indicates that cure can only be achieved with cytoreductive surgery (CRS) which is often indicated with concurrent adjuvant ...
D. Yap +5 more
semanticscholar +1 more source
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature. [PDF]
BackgroundHereditary colon cancer is characterized by the inheritance of an abnormal gene mutation which predisposes to malignancy. Recent advances in genomic medicine have identified mutations in "novel" genes as conferring an increased risk of ...
Ali, Mir +2 more
core
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki +6 more
wiley +1 more source
Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. [PDF]
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis.
Demartines, N. +6 more
core +3 more sources
Background Up to 15 per cent of colorectal cancers present with peritoneal metastases (CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS + HIPEC) aims to achieve macroscopic tumour resection combined with HIPEC to destroy ...
S. Hallam +4 more
doaj +1 more source
ABSTRACT Background Cross‐resistance is observed between platinum and Poly (ADP‐ribose) polymerase inhibitors (PARPi). We aim to propose the definition of PARPi resistance and demonstrate the best therapeutic strategy for patients with PARPi resistance.
Rui Gou +13 more
wiley +1 more source
Background Colorectal cancer is the third-most common malignancy worldwide. It has the potential to develop peritoneal metastases (CRPM), which can be treated using cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Raymond Hayler +8 more
doaj +1 more source
Hyperthermic intraperitoneal chemotherapy: Ideal and reality
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong +8 more
doaj +1 more source
Hypertherme intraperitoneale chemotherapie (HIPEC)
Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Hemmer, Patrick, Van Leeuwen, Barbara
openaire +2 more sources
ABSTRACT Although rare, appendiceal cancer can metastasize to unusual sites, including the inguinal canal. In patients with a history of abdominal malignancy presenting with an inguinal hernia, metastatic disease should be considered for adequate recognition and early oncologic intervention.
Peter Mounas +3 more
wiley +1 more source

